Irritable Bowel Syndrome and Digestive Health Support Forum banner
1 - 1 of 1 Posts

·
Banned
Joined
·
7,295 Posts
Discussion Starter · #1 ·
GSK Lotronex Risk Could Be Explored Through Patient Use Survey, IBS Group SuggestsGlaxoSmithKline�s Lotronex risk potential could be characterized by a survey of irritable bowel syndrome patients who are willing to take the drug, the Lotronex Action Group said in comments prepared for FDA�s Risk Management Subcommittee's April 23 meeting.Complete story is here: http://www.ibsgroup.org/other/FDAReports2002Apr19.html Posted: Friday, April 19, 2002Copywrite FDC Reports, Inc.
 
1 - 1 of 1 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Top